^
BIOMARKER:

Tregs-H

i
Other names: Tregs
News
Twitter
Trials
Tregs-H
HCC
bevacizumab + atezolizumab
Sensitive: C3 – Early Trials
Tregs-H
RCC
nivolumab
Sensitive: C3 – Early Trials